Chemoinformaics analysis of Dihydrodehydrodiconiferyl Alcohol
| Molecular Weight | 360.406 | nRot | 7 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 16 |
| Exact Molecular Weight | 360.157 | nRing | 3 |
| Solubility: LogS | -3.637 | nHRing | 1 |
| Solubility: LogP | 1.803 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 54.215 |
| nHD | 3 | BPOL | 29.285 |
| QED | 0.703 |
| Synth | 3.267 |
| Natural Product Likeliness | 1.717 |
| NR-PPAR-gamma | 0.668 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.242 |
| Pgp-sub | 0.004 |
| HIA | 0.011 |
| CACO-2 | -4.779 |
| MDCK | 0.0000122 |
| BBB | 0.133 |
| PPB | 0.705814 |
| VDSS | 1.295 |
| FU | 0.106517 |
| CYP1A2-inh | 0.066 |
| CYP1A2-sub | 0.849 |
| CYP2c19-inh | 0.123 |
| CYP2c19-sub | 0.823 |
| CYP2c9-inh | 0.276 |
| CYP2c9-sub | 0.746 |
| CYP2d6-inh | 0.108 |
| CYP2d6-sub | 0.814 |
| CYP3a4-inh | 0.697 |
| CYP3a4-sub | 0.881 |
| CL | 9.11 |
| T12 | 0.612 |
| hERG | 0.052 |
| Ames | 0.145 |
| ROA | 0.274 |
| SkinSen | 0.666 |
| Carcinogencity | 0.096 |
| EI | 0.013 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.799 |
| Antiviral | Yes |
| Prediction | 0.538747 |